Published in Ter Arkh on January 01, 1991
Aggregation and disaggregation of erythrocytes in whole blood: study by backscattering technique. J Biomed Opt (1999) 0.92
[Rosenthal's syndrome (hemophilia C) in a patient with psoriatic arthritis (a clinical case)]. Ter Arkh (1997) 0.85
[Dynamic changes in synovitis activity after intra-articular administration of xefocam in patients with rheumatoid arthritis (according to clinical and device examinations)]. Ter Arkh (2003) 0.84
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
[Auriculo-electropuncture in rheumatoid arthritis (a double-blind study)]. Ter Arkh (1987) 0.80
[Madecassol treatment of systemic and localized scleroderma]. Ter Arkh (1998) 0.79
[Cardiovascular diseases in rheumatoid arthritis]. Ter Arkh (2007) 0.77
[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]. Ter Arkh (2009) 0.77
[The local therapy of enthesitis and bursitis of the calcaneal area in seronegative spondylarthritis]. Ter Arkh (1997) 0.76
[The mechanism of the prevention by ethomersol of disorders in erythrocyte deformability in cerebral ischemia and recirculation]. Eksp Klin Farmakol (1993) 0.76
[Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2006) 0.76
[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Ter Arkh (2008) 0.76
[Cartilage-protective preparations in the therapy of osteoarthrosis]. Ter Arkh (1992) 0.75
[Urogenital infection in Reiter's disease, rheumatoid arthritis and Bechterew's disease]. Ter Arkh (1980) 0.75
[Thrombo ASS in the prophylaxis of vascular disorders in antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.75
[Place of hemocarboperfusion and hyperbaric oxygenation in the treatment of patients with rheumatoid arthritis with systemic symptoms]. Ter Arkh (1986) 0.75
[Autoimmune reactions to synovial membrane and articular cartilage in rheumatoid arthritis]. Ter Arkh (1978) 0.75
[Effect of hyperbaric oxygenation on the microcirculatory state in clinically manifest rheumatoid vasculitis]. Ter Arkh (1982) 0.75
[Vascular symptoms of Behcet's disease]. Ter Arkh (2005) 0.75
[Clinical aspects of rheumatic polymyalgia]. Ter Arkh (1976) 0.75
[Cardiovascular risk in psoriatic arthritis]. Ter Arkh (2009) 0.75
[Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome]. Ter Arkh (1995) 0.75
[An assessment of tissue microcirculation in patients with aseptic femur head necrosis in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[Treatment of Raynaud's syndrome with calcium entry blockers]. Ter Arkh (1987) 0.75
[Microcirculatory disorders in vasculitis of the skin]. Vestn Dermatol Venerol (1984) 0.75
[Use of laser Doppler flowmetry in various rheumatic diseases]. Revmatologiia (Mosk) (1988) 0.75
[Rate of absorption of Na24Cl and I-131-hippuran from the intramuscular depot]. Med Radiol (Mosk) (1970) 0.75
[Assessment of tissue microcirculation in patients with aseptic necrosis of femur heads in systemic lupus erythematosus (SLE)]. Ter Arkh (1999) 0.75
[Yersinia enterocolitica and rheumatic diseases (a review of the literature)]. Vopr Revm (1979) 0.75
[The vasoprostan treatment of patients with Raynaud's syndrome]. Ter Arkh (1997) 0.75
[Nonrheumatic myocarditis (clinico-pathogenetic aspects)]. Ter Arkh (1982) 0.75
[Systemic sclerosis with a rapidly progressing course]. Ter Arkh (1981) 0.75
[Value of determination of skin microcirculation in systemic lupus erythematosus]. Ter Arkh (1979) 0.75
[Atheroscleotic vascular lesion in systemic lupus erythematosus and antiphospholipid syndrome in men]. Klin Med (Mosk) (2006) 0.75
[Symptomatology of spinal lesions in Reiter's disease and psoriatic arthritis]. Ter Arkh (1980) 0.75
[Late results of the D-penicillamine treatment of rheumatoid arthritis]. Vopr Revm (1982) 0.75
[Microcirculatory disorders in systemic scleroderma treated with d-penicillamine]. Klin Med (Mosk) (1981) 0.75
[Antiphospholipid syndrome and exogenic risk factors in thromboses]. Ter Arkh (2004) 0.75
[The condition of peripheral arteries in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2004) 0.75
[Status of tissue microcirculation in psoriatic arthritis]. Ter Arkh (1986) 0.75
[Methods for the instrumental diagnosis and verification of Lyme arthritis]. Ter Arkh (1997) 0.75
[Comparative evaluation of tissue microcirculation in patients with aseptic necrosis of the femur head in rheumatoid arthritis and systemic lupus erythematosus]. Ter Arkh (2001) 0.75
[Comparative evaluation of the treatment of Sjögren's syndrome with anti-rheumatic preparations]. Ter Arkh (1988) 0.75
[Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis]. Ter Arkh (2008) 0.75
[Clinical significance of the assessment of cardiac rhythm variability in patients with rheumatoid arthritis]. Klin Med (Mosk) (2009) 0.75
[Significance of bone marrow endothelial progenitor cells in disturbance of angiogenesis and endothelial dysfunction in systemic scleroderma]. Vestn Ross Akad Med Nauk (2008) 0.75
[Vladimir Nikitich Vinogradov (100th anniversary of his birth)]. Kardiologiia (1982) 0.75
[Atherosclerotic lesion of the vessels in systemic lupus erythematosus in males: relations with concentration of C-reactive protein]. Ter Arkh (2005) 0.75
[Arthrography of shoulder joints in patients with humeroscapular periarthritis]. Ter Arkh (1982) 0.75
[Corticosteroids in the treatment of secondary antiphospholipid syndrome]. Klin Med (Mosk) (2002) 0.75
[Clinical diagnosis and activity of the process in several variants of the course of infectious nonspecific polyarthritis]. Vopr Revm (1970) 0.75
[Diagnosis of monoarthritis of the knee joint]. Ter Arkh (1979) 0.75
[The clinical instrumental characteristics of the locomotor involvement in patients who have had Lyme disease]. Ter Arkh (1995) 0.75
[Mutation of a 5,10-methylenetetrahydrofolate reductase gene in systemic lupus erythematosis and antiphospholipid syndrome]. Ter Arkh (2002) 0.75
[Effect of combined treatment with nicotinic acid and DMSO on microcirculatory disorders in systemic scleroderma]. Ter Arkh (1978) 0.75
[Simplified method of simultaneous determination of the resorption rate of 2 radioindicators taken from the tissue]. Vopr Revm (1972) 0.75
[Hemodynamics and tolerance to physical exertion in patients with acute rheumatism]. Ter Arkh (1983) 0.75
[Clinico-instrumental evaluation of the laser therapy of rheumatoid arthritis]. Revmatologiia (Mosk) (1984) 0.75
[Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients]. Ter Arkh (2009) 0.75
[Comparative clinico-immunologic and microcirculation studies in families of patients with type 1 diabetes mellitus and systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Intra-articular application of radioactive gold in infectious nonspecific polyarthritis]. Vopr Revm (1974) 0.75
[Achievements of modern antirheumatism therapy]. Klin Med (Mosk) (1982) 0.75
[Articular lesions in Ixodes tick-borne borreliosis (Lyme disease)]. Vestn Ross Akad Med Nauk (2003) 0.75
[Experience with the D-penicillamine treatment of rheumatoid arthritis]. Vopr Revm (1978) 0.75
[Etiological role of Halprovia-microorganisms of PLT group in diseases of joints. I. Excretion of Halprovia arthritidis from joints of patients with rheumatoid monosynovitis and Reiter's syndrome]. Vopr Revm (1974) 0.75
[Differential diagnosis of diffuse eosinophilic fasciitis]. Revmatologiia (Mosk) (1990) 0.75
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)]. Ter Arkh (1985) 0.75
[Endothelial dysfunction in scleroderma systematica: clinicopathogenetic correlations]. Ter Arkh (2008) 0.75
[Clinical variants and the morphological picture of the joint syndrome in patients with psoriasis]. Ter Arkh (1983) 0.75
[Primary antiphospholipid syndrome in combination with heterozygous mutation in prothrombin (G20210A) gene: a case report]. Klin Med (Mosk) (2002) 0.75
[Rheumatic polymyalgia]. Vopr Revm (1977) 0.75
[Dimethylsulfoxide as a vehicle for vasoactive drugs in the treatment of systemic scleroderma]. Ter Arkh (1982) 0.75
[Current state of the arthrosis problem]. Vopr Revm (1970) 0.75
[Sclerodermic pneumofibrosis (clinical-functional characteristics)]. Ter Arkh (1969) 0.75
[Activity of lysosomal enzymes in the blood and synovial fluid in joint diseases]. Ter Arkh (1977) 0.75
[Clinical and laboratory characteristics of different forms and variants of the course of rheumatoid arthritis]. Vopr Revm (1977) 0.75
[Possible etiological role of Halprovia (microorganisms of PLT group) in the development of nonspecific inflammatory diseases of the joints]. Ter Arkh (1973) 0.75
[Symptoms of clinico-anatomical variants of humeroscapular periarthritis (periarthrosis)]. Revmatologiia (Mosk) (1983) 0.75
[Extracorporeal therapy (hemosorption, plasmapheresis) in the combined treatment of severe forms of Sjögren's disease]. Vutr Boles (1988) 0.75
[Soluble receptors of TNF-alpha: association with atherosclerotic vascular affection in systemic lupus erythematosus in males]. Ter Arkh (2006) 0.75
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]. Ter Arkh (1980) 0.75
[Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]. Ter Arkh (2003) 0.75
[The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus]. Klin Med (Mosk) (2006) 0.75
[Soluble CD40 ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection]. Ter Arkh (2008) 0.75
[Muscular pathology in rheumatoid arthritis: a clinico-morphological study]. Klin Med (Mosk) (1996) 0.75
[The cerebral blood circulation in patients with systemic lupus erythematosus and the antiphospholipid syndrome]. Ter Arkh (1994) 0.75
[The role of suprasegmental and segmental autonomic disorders in the development of muscular syndrome of rheumatoid arthritis]. Ter Arkh (2002) 0.75
[Clinical significance of heart rate variability in patients with systemic lupus erythematosus]. Ter Arkh (2008) 0.75
[Epidemiological criteria for diagnosing infectious nonspecific polyarthritis]. Vopr Revm (1971) 0.75
[Clinical aspects and the course of infectious nonspecific polyarthritis according to data of the Arthrological department of Moscow City Hospital No. 13]. Sov Med (1966) 0.75
[Acute rheumatic polyarthritis in young men]. Ter Arkh (1991) 0.75
[Study of sulfopolysaccharides of the synovial fluid in infectious nonspecific polyarthritis to characterize destructive processes in joints]. Vopr Revm (1970) 0.75
[Current studies on etiology of rheumatoid arthritis and related diseases]. Ter Arkh (1977) 0.75
[Clinical symptomatology and various problems of treatment of Reĭter's disease]. Ter Arkh (1978) 0.75
[Scintigraphy with 99mTc-pyrophosphate in patients with scapulohumeral periarthritis]. Ter Arkh (1981) 0.75
[Effect of vazaprostan on microcirculation in patients with scleroderma systematic]. Ter Arkh (2000) 0.75
[Microcirculatory disorders in the genesis of sclerodermic nephropathy]. Ter Arkh (1986) 0.75